Namwiwat Medical PCL (BKK:NAM) EV-to-EBIT : 13.48 (As of Jan. 18, 2025)

View and export this data going back to 2023. Start your Free Trial

What is Namwiwat Medical PCL EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Namwiwat Medical PCL's Enterprise Value is ฿2,249.4 Mil. Namwiwat Medical PCL's EBIT for the trailing twelve months (TTM) ended in Sep. 2024 was ฿166.8 Mil. Therefore, Namwiwat Medical PCL's EV-to-EBIT for today is 13.48.

The historical rank and industry rank for Namwiwat Medical PCL's EV-to-EBIT or its related term are showing as below:

BKK:NAM' s EV-to-EBIT Range Over the Past 10 Years
Min: 13.4 Med: 29.71 Max: 60.06
Current: 13.48

During the past 4 years, the highest EV-to-EBIT of Namwiwat Medical PCL was 60.06. The lowest was 13.40. And the median was 29.71.

BKK:NAM's EV-to-EBIT is ranked better than
68.09% of 445 companies
in the Medical Devices & Instruments industry
Industry Median: 19.59 vs BKK:NAM: 13.48

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Namwiwat Medical PCL's Enterprise Value for the quarter that ended in Sep. 2024 was ฿2,669.4 Mil. Namwiwat Medical PCL's EBIT for the trailing twelve months (TTM) ended in Sep. 2024 was ฿166.8 Mil. Namwiwat Medical PCL's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Sep. 2024 was 6.25%.

Namwiwat Medical PCL EV-to-EBIT Historical Data

The historical data trend for Namwiwat Medical PCL's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Namwiwat Medical PCL EV-to-EBIT Chart

Namwiwat Medical PCL Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

EV-to-EBIT

15.03

Namwiwat Medical PCL Quarterly Data
	Dec21	Jun22	Dec22	Jun23	Dec23	Mar24	Jun24	Sep24
EV-to-EBIT	Get a 7-Day Free Trial			-	15.03	34.25	32.64	16.00

Competitive Comparison of Namwiwat Medical PCL's EV-to-EBIT

For the Medical Devices subindustry, Namwiwat Medical PCL's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Namwiwat Medical PCL's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Namwiwat Medical PCL's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Namwiwat Medical PCL's EV-to-EBIT falls into.

Namwiwat Medical PCL EV-to-EBIT Calculation

Namwiwat Medical PCL's EV-to-EBIT for today is calculated as:

EV-to-EBIT	=	Enterprise Value (Today)	/	EBIT (TTM)
	=	2249.360	/	166.844
	=	13.48

Namwiwat Medical PCL's current Enterprise Value is ฿2,249.4 Mil.
Namwiwat Medical PCL's EBIT for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ฿166.8 Mil.

Namwiwat Medical PCL (BKK:NAM) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Namwiwat Medical PCL's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Sep. 2024 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Sep. 2024 )	=	EBIT	/	Enterprise Value (Q: Sep. 2024 )
	=	166.844	/	2669.36
	=	6.25 %

Namwiwat Medical PCL's Enterprise Value for the quarter that ended in Sep. 2024 was ฿2,669.4 Mil.
Namwiwat Medical PCL's EBIT for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ฿166.8 Mil.

Namwiwat Medical PCL EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Namwiwat Medical PCL's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Namwiwat Medical PCL Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Namwiwat Medical Corp PCL (BKK:NAM) » Definitions » EV-to-EBIT

Comparable Companies

Traded in Other Exchanges

N/A

Address

999/3-5 Moo 9 Pracha Uthit-Khu Sang Road, Nai Khlong Bang Pla Kot, Phra Samut Chedi, Samut Prakan, THA, 10290

Website

https://www.namwiwat.com

Namwiwat Medical Corp PCL operates a manufacturing business Importing and distributing Medical tools and equipment for cleaning and disinfecting medical equipment in hospitals and nursing homes in accordance with public health standards. Company operates in four reportable segments (1) Medical equipment manufacturing and distribution segment (2) Medical supplies manufacturing and distribution segment (3) CSSD disinfection Medical equipment maintenance services segment and waste services segment (4) Construction contractual. The Group operates its business in one geography, only in Thailand.

Namwiwat Medical PCL Headlines

No Headlines